Related Experiment Video
Updated: Mar 6, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary
Debbie C Chen1, Gagan D Singh2, Ehrin J Armstrong3
1Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Insights
Patients with peripheral artery disease (PAD) and coronary artery disease (CAD) showed higher guideline-directed medical therapy (GDMT) use but increased mortality risk. Concomitant CAD significantly elevated mortality risk in PAD patients over five years.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Clinical Outcomes Research
Background:
- Guideline-directed medical therapy (GDMT) is crucial for managing peripheral artery disease (PAD).
- Limited contemporary data exist on GDMT utilization and long-term outcomes in PAD patients with concurrent coronary artery disease (CAD).
- Understanding these outcomes is vital for optimizing patient care and risk stratification.
Purpose of the Study:
- To evaluate GDMT utilization in PAD patients with and without concomitant CAD.
- To determine the long-term clinical outcomes, including major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause mortality, in these patient groups.
- To identify CAD as an independent risk factor for adverse outcomes in PAD.
Main Methods:
- Retrospective analysis of 879 patients with claudication or critical limb ischemia (CLI) undergoing vascular procedures from 2006-2013.
- Assessment of GDMT use at the time of angiography.
- 5-year follow-up for MACCE and all-cause mortality, analyzed using Cox proportional hazard modeling.
Main Results:
- Patients with PAD and concomitant CAD demonstrated higher adherence to GDMT (aspirin, ACEI/ARB, statins).
- Unadjusted 5-year rates of MACCE and all-cause mortality were significantly higher in patients with PAD and CAD (HR 1.7 and 1.86, respectively).
- Adjusted analysis revealed CAD as an independent risk factor for mortality (aHR 1.35) but not MACCE in PAD patients. In CLI patients, CAD independently increased MACCE (aHR 1.52) and mortality (aHR 1.64).
Conclusions:
- Despite superior GDMT use, PAD patients with concurrent CAD face a substantially elevated risk of all-cause mortality over five years post-procedure.
- Concomitant CAD poses a particularly high risk for both MACCE and mortality in the critical limb ischemia (CLI) subgroup.
- These findings underscore the need for intensified management strategies in PAD patients with coexisting CAD.
Abstract:
There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery disease (PAD) with and without concomitant coronary artery disease (CAD). From 2006 to 2013, 879 patients with claudication or critical limb ischemia (CLI) underwent diagnostic angiography or therapeutic endovascular intervention at our multidisciplinary vascular center. GDMT use was assessed at the time of angiography, and major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause mortality were determined during 5 years of follow-up. Cox proportional hazard modeling was used to adjust for baseline differences between patients with and without concomitant CAD. Despite a higher adherence to GDMT (all p ≤0.002) for the use of aspirin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and statins, patients with PAD and concomitant CAD had higher unadjusted 5-year rates of MACCE (hazard ratio [HR] 1.7, 95% CI 1.3 to 2.1, p = 0.0001) and all-cause mortality (HR 1.86, 95% CI 1.4 to 2.4, p = 0.0001). After adjustment for baseline co-morbidities, the presence of CAD remained an independent risk factor for mortality (adjusted HR 1.35, 95% CI 1.02 to 1.80, p = 0.04) but not for MACCE (adjusted HR 1.24, 95% CI 0.96 to 1.60, p = 0.10) in patients with PAD. A sensitivity analysis limited to patients with CLI demonstrated that concomitant CAD was associated with significantly higher adjusted rates of both MACCE (adjusted HR 1.52, 95% CI 1.14 to 2.03, p = 0.01) and mortality (adjusted HR 1.64, 95% CI 1.12 to 2.20, p = 0.006). In conclusion, despite higher rates of GDMT use, PAD patients with concomitant CAD had significantly increased risk of all-cause mortality during a 5-year postprocedural follow-up. The subgroup of CLI patients with concomitant CAD was at particularly high risk for both MACCE and all-cause mortality.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease I: Introduction
